Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Silicosis Workup

  • Author: Basil Varkey, MD, FCCP; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
 
Updated: Dec 16, 2015
 

Laboratory Studies

Although various serologic abnormalities have been noted in patients with silicosis, they are not diagnostic of the disease, and tests to detect these abnormalities are not indicated routinely (see Other Tests).

Humoral immune system abnormalities observed in silicosis include increased incidence and titer of rheumatoid factor, antinuclear antibodies, and immune complexes. No consistent abnormality is noted in the cell-mediated immune system.

Next

Imaging Studies

Chest radiograph

Radiographic studies of the chest are essential to the diagnosis of silicosis. While some chest radiographic findings of silicosis may be nonspecific, others are sufficiently characteristic of the disease.

Bilateral alveolar filling and a ground-glass appearance mimicking alveolar proteinosis are observed in silicoproteinosis.

Simple silicosis manifests as multiple small (< 10 mm) nodules that are scattered diffusely throughout the lungs but may be more prominent in the upper lung fields. These radiographic findings have been found to correlate well with pathologic findings. Chest radiographic findings in persons with simple silicosis have a high degree of sensitivity and specificity. Calcification of the hilar lymph nodes, particularly in the rim of the nodes (ie, eggshell calcification) is very characteristic of silicosis. However, eggshell calcifications are observed only in a minority of cases of silicosis. Other causes of eggshell calcification include sarcoidosis, histoplasmosis, and irradiation. Rarely, the pulmonary nodules also may show calcification.

Progressive massive fibrosis (PMF) manifests as bilateral upper lobe masses, which are formed by the coalescence of nodules. Cavitation may be seen. As these masses retract toward the hilum because of fibrosis, the lower lung fields may appear overinflated. Hilar calcifications may be present.

CT scan

A high-resolution CT scan has more sensitivity than chest radiography in discerning the nodules of simple silicosis but is unnecessary if the chest radiographic appearance shows characteristic nodules.

In progressive massive fibrosis, a CT scan provides more detail of emphysematous changes, pleural thickening, and the confluent masslike lesions (eg, the presence of cavitation) than a chest radiograph. Although cavitation in silicosis can occur without a mycobacterial infection, such a possibility should be considered when cavitation is observed.

Although pleural effusions are quite rare, pleural thickening is not an unusual finding.

Previous
Next

Other Tests

Pulmonary function test (spirometry) results may be normal in simple silicosis. However, silicosis is associated with an excessive decline in lung function. In more advanced disease, airflow obstruction or a mixed pattern of obstruction and restriction is observed. In smokers with airflow obstruction, separating the effect of silicosis from the confounding factor of tobacco smoke is difficult. Progressive massive fibrosis causes severe restriction, decreased compliance, and hypoxemia.

A tuberculin skin test using purified protein derivative (PPD) is indicated in all persons with silicosis. If the test result is positive (ie, 10 mm or more of induration at the site), treatment for latent or active infection is indicated. In individuals who have a positive skin test result, sputum samples should be examined for acid-fast bacilli (AFB) by microscopy and cultured for AFB to identify active disease.

Previous
Next

Procedures

Bronchoscopy rarely is needed. The rare indication is in a cavitary or mass lesion when mycobacterial disease or lung cancer is suspected and examination of sputum samples is nondiagnostic.

Previous
Next

Histologic Findings

The diagnosis of silicosis is based on history of exposure, chest radiographic appearance consistent with silicosis, and an absence of other diagnoses that simulate the radiographic abnormalities of silicosis. Clinical manifestations, symptoms, and physical examination findings provide support to the diagnosis. Thus, examination of lung tissue is seldom warranted.

The initial histopathologic changes of silicosis are pigmented macrophages and reticulin fibers in peribronchial, paraseptal, and perivascular areas.

The characteristic histopathologic finding is the silicotic nodule mostly located near the respiratory bronchiole. The nodule is composed of refractile particles of silica surrounded by whorled collagen in concentric layers, with macrophages, lymphocytes, and fibroblasts in the periphery. Emphysematous blebs surround the silicotic nodule, especially in the subpleural area. Birefringent crystals of silica in the center of a silicotic nodule may be identified by polarized light microscopy. For definitive identification, scanning electron microscopy combined with x-ray spectroscopy may be needed.

In PMF, the masslike areas may show cavitation caused by a necrotic process.

Acute silicosis silicotic nodules are seldom seen and the histology is similar to pulmonary alveolar proteinosis with alveolar filling with proteinaceous material that stains with periodic acid-Schiff stain.

Previous
 
 
Contributor Information and Disclosures
Author

Basil Varkey, MD, FCCP Professor Emeritus, Department of Internal Medicine, Division of Pulmonary and Critical Care, Medical College of Wisconsin; Consulting Pulmonologist, Froedtert Memorial Lutheran Hospital

Basil Varkey, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American Association of Physicians of Indian Origin

Disclosure: Nothing to disclose.

Coauthor(s)

Anita B Varkey, MD Assistant Professor, Department of Medicine, Loyola University Medical Center; Associate Program Director, Internal Medicine Residency; Medical Director, General Internal Medicine Clinic, Loyola Outpatient Center

Anita B Varkey, MD is a member of the following medical societies: American College of Physicians, Society of General Internal Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

Disclosure: Nothing to disclose.

Additional Contributors

Gregory Tino, MD Director of Pulmonary Outpatient Practices, Associate Professor, Department of Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania Medical Center and Hospital

Gregory Tino, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012 May 26. 379(9830):2008-18. [Medline].

  2. Centers for Disease Control and Prevention. Silicosis-related years of potential life lost before age 65 years--United States, 1968-2005. MMWR Morb Mortal Wkly Rep. 2008 Jul 18. 57(28):771-5. [Medline].

  3. Rosenman KD, Reilly MJ, Kalinowski DJ, Watt FC. Silicosis in the 1990s. Chest. 1997 Mar. 111(3):779-86. [Medline].

  4. Sonnenberg P, Murray J, Glynn JR, Thomas RG, Godfrey-Faussett P, Shearer S. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J. 2000 Feb. 15(2):291-6. [Medline].

  5. de Oliveira Abrao C, de Araujo Filho JA. Mycobacterium sherrisii lung infection in a Brazilian patient with silicosis and a history of pulmonary tuberculosis. Case Rep Infect Dis. 2015. 2015:498608. [Medline].

  6. Chen S, Yuan J, Yao S, et al. Lipopolysaccharides may aggravate apoptosis through accumulation of autophagosomes in alveolar macrophages of human silicosis. Autophagy. 2015 Nov 9. [Medline].

  7. Caplan A, Payne RB, Withley JL. A broadened concept of Caplan's syndrome related to rheumatoid factors. Thorax. 1962. 17:205-209.

  8. Yucesoy B, Vallyathan V, Landsittel DP, et al. Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med. 2001 Mar. 39(3):286-91. [Medline].

  9. Verma DK, Vacek PM, des Tombe K, et al. Silica exposure assessment in a mortality study of vermont granite workers. J Occup Environ Hyg. 2011 Feb. 8(2):71-9. [Medline].

  10. Palabiyik SS, Girgin G, Tutkun E, Yilmaz OH, Baydar T. Immunomodulation and oxidative stress in denim sandblasting workers: changes caused by silica exposure. Arh Hig Rada Toksikol. 2013 Sep 1. 64(3):431-7. [Medline].

  11. Chaudhury N, Phatak A, Paliwal R, Raichaudhari C. Silicosis among agate workers at Shakarpur: An analysis of clinic-based data. Lung India. 2010 Oct. 27(4):221-4. [Medline]. [Full Text].

  12. Linch KD. Respirable concrete dust--silicosis hazard in the construction industry. Appl Occup Environ Hyg. 2002 Mar. 17(3):209-21. [Medline].

  13. Centers for Disease Control and Prevention. Silicosis in dental laboratory technicians--five states, 1994-2000. MMWR Morb Mortal Wkly Rep. 2004 Mar 12. 53(9):195-7. [Medline].

  14. Goodman GB, Kaplan PD, Stachura I, Castranova V, Pailes WH, Lapp NL. Acute silicosis responding to corticosteroid therapy. Chest. 1992 Feb. 101(2):366-70. [Medline].

  15. Gupta RC, Vats M, Dadhich P, Gupta N, Taylor M. Steroid pulse therapy in silicosis. Chest. 2003. 124(4):215S.

  16. Sharma SK, Pande JN, Verma K. Effect of prednisolone treatment in chronic silicosis. Am Rev Respir Dis. 1991 Apr. 143(4 Pt 1):814-21. [Medline].

  17. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003 Jun 20. 52:1-77. [Medline].

  18. Rosenman KD, Moore-Fuller M, Reilly MJ. Connective tissue disease and silicosis. Am J Ind Med. 1999 Apr. 35(4):375-81. [Medline].

  19. Mulloy KB. Silica exposure and systemic vasculitis. Environ Health Perspect. 2003 Dec. 111(16):1933-8. [Medline].

  20. Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol. 2007 Mar. 2(2):290-9. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.